{"transactions":[{"id":678429,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-21T20:08:02.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":1697,"price":27,"value":45819.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."}],"balance_after":117592,"source":{"system":"sec-edgar","filing":"0001628280-26-058420","document":"wk-form4_1787342879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026058420/wk-form4_1787342879.xml","form_type":"4"}},{"id":687679,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-14T00:06:49.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":128750,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001628280-26-056898","document":"wk-form4_1786666006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026056898/wk-form4_1786666006.xml","form_type":"4"}},{"id":687678,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-14T00:06:49.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":135450,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001628280-26-056898","document":"wk-form4_1786666006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026056898/wk-form4_1786666006.xml","form_type":"4"}},{"id":687677,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-14T00:06:49.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":6700,"price":26.0847,"value":174767.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":119289,"source":{"system":"sec-edgar","filing":"0001628280-26-056898","document":"wk-form4_1786666006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026056898/wk-form4_1786666006.xml","form_type":"4"}},{"id":687676,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-14T00:06:49.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":6700,"price":3.64,"value":24388.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":125989,"source":{"system":"sec-edgar","filing":"0001628280-26-056898","document":"wk-form4_1786666006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026056898/wk-form4_1786666006.xml","form_type":"4"}},{"id":687675,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-14T00:06:49.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":8300,"price":26.5216,"value":220129.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.50 to $26.57, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":119289,"source":{"system":"sec-edgar","filing":"0001628280-26-056898","document":"wk-form4_1786666006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026056898/wk-form4_1786666006.xml","form_type":"4"}},{"id":687674,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-14T00:06:49.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":true,"shares":8300,"price":3.64,"value":30212.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":127589,"source":{"system":"sec-edgar","filing":"0001628280-26-056898","document":"wk-form4_1786666006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026056898/wk-form4_1786666006.xml","form_type":"4"}},{"id":695214,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-06T01:42:23.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":955,"price":26.1168,"value":24941.544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.72 to $26.69, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":119289,"source":{"system":"sec-edgar","filing":"0001628280-26-053755","document":"wk-form4_1785980541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026053755/wk-form4_1785980541.xml","form_type":"4"}},{"id":780355,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-13T23:42:35.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":222,"price":21.05,"value":4673.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."}],"balance_after":120244,"source":{"system":"sec-edgar","filing":"0001741987-26-000004","document":"wk-form4_1778715752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198726000004/wk-form4_1778715752.xml","form_type":"4"}},{"id":789460,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-06T22:15:16.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":684,"price":23.6106,"value":16149.6504,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.16 to $23.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":120466,"source":{"system":"sec-edgar","filing":"0001741987-26-000002","document":"wk-form4_1778105713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198726000002/wk-form4_1778105713.xml","form_type":"4"}},{"id":864829,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-04T01:41:49.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":77000,"derivative":{"exercise_price":26.97,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001628280-26-014324","document":"wk-form4_1772588506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026014324/wk-form4_1772588506.xml","form_type":"4"}},{"id":864828,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:41:49.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":181,"price":25.914,"value":4690.434,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.71 to $26.70, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Due to a scrivener's error on the Reporting Person's Form 4s filed since November 5, 2025, the number of shares of common stock beneficially owned by the Reporting Person reflected a discrepancy that inadvertently understated the Reporting Person's ownership by a range of 18 to 36 shares. The corrected number of shares beneficially owned is reflected in this Form 4."}],"balance_after":121150,"source":{"system":"sec-edgar","filing":"0001628280-26-014324","document":"wk-form4_1772588506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026014324/wk-form4_1772588506.xml","form_type":"4"}},{"id":864827,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:41:49.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":6106,"price":25.1604,"value":153629.4024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.69 to $25.67, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":121295,"source":{"system":"sec-edgar","filing":"0001628280-26-014324","document":"wk-form4_1772588506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026014324/wk-form4_1772588506.xml","form_type":"4"}},{"id":864826,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:41:49.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Constitute RSUs for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the \"Vesting Commencement Date\"), of each year beginning March 1, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":127401,"source":{"system":"sec-edgar","filing":"0001628280-26-014324","document":"wk-form4_1772588506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026014324/wk-form4_1772588506.xml","form_type":"4"}},{"id":864825,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:41:49.000Z","date":"2022-08-18","kind":"grant","planned":true,"acquired":true,"shares":16750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 8, 2020, the Reporting Person was granted performance-based Restricted Stock Units (\"RSUs\") subject to a milestone condition. The Compensation Committee of the Issuer certified the achievement of the milestone and commencement of vesting on August 18, 2022. The remaining RSUs vested in three substantially equal annual installments, such that the RSUs fully vested on August 18, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects holdings following the August 18, 2022 transaction reported herein."}],"balance_after":97401,"source":{"system":"sec-edgar","filing":"0001628280-26-014324","document":"wk-form4_1772588506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026014324/wk-form4_1772588506.xml","form_type":"4"}},{"id":918941,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T00:30:00.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":9794,"price":25.8064,"value":252747.8816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.58 to $26.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":80651,"source":{"system":"sec-edgar","filing":"0001628280-26-005571","document":"wk-form4_1770251397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026005571/wk-form4_1770251397.xml","form_type":"4"}},{"id":918940,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T00:30:00.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":3675,"price":25.4984,"value":93706.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligation in connection with the vesting of Restricted Stock Units (\"RSUs\"), granted on January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the \"Vesting Commencement Date\"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.745 to $25.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":90445,"source":{"system":"sec-edgar","filing":"0001628280-26-005571","document":"wk-form4_1770251397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026005571/wk-form4_1770251397.xml","form_type":"4"}},{"id":943977,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-07T22:46:47.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":2490,"price":28.9822,"value":72165.678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.77 to $29.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":94120,"source":{"system":"sec-edgar","filing":"0001628280-26-001241","document":"wk-form4_1767826005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026001241/wk-form4_1767826005.xml","form_type":"4"}},{"id":954855,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-02T23:12:23.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":1156,"price":29.3893,"value":33974.0308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units, granted on August 3, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units, granted on August 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $29.0829 to $29.57, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":96610,"source":{"system":"sec-edgar","filing":"0001628280-26-000209","document":"wk-form4_1767395540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026000209/wk-form4_1767395540.xml","form_type":"4"}},{"id":954854,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-02T23:12:23.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":541,"price":28.81,"value":15586.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units, granted on August 3, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units, granted on August 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.08 to $29.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":97766,"source":{"system":"sec-edgar","filing":"0001628280-26-000209","document":"wk-form4_1767395540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000162828026000209/wk-form4_1767395540.xml","form_type":"4"}},{"id":964148,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-17T22:53:56.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting\nCommencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting\nPerson's continued service to the Issuer."}],"balance_after":143750,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001741987-25-000010","document":"wk-form4_1766012033.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000010/wk-form4_1766012033.xml","form_type":"4"}},{"id":964147,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-17T22:53:56.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":11500,"price":28.9436,"value":332851.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.61 to $29.20, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":98307,"source":{"system":"sec-edgar","filing":"0001741987-25-000010","document":"wk-form4_1766012033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000010/wk-form4_1766012033.xml","form_type":"4"}},{"id":964146,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-17T22:53:56.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":11500,"price":3.64,"value":41860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to a scrivener's error on the Reporting Person's Form 4 filed on November 5, 2025, the number of shares of common stock beneficially owned by the Reporting Person was inadvertently overstated by 18 shares. The corrected number of shares beneficially owned is reflected in this Form 4."}],"balance_after":109807,"source":{"system":"sec-edgar","filing":"0001741987-25-000010","document":"wk-form4_1766012033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000010/wk-form4_1766012033.xml","form_type":"4"}},{"id":1003404,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-10T22:41:59.000Z","date":"2025-11-06","kind":"exercise","planned":true,"acquired":false,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting\nCommencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting\nPerson's continued service to the Issuer."}],"balance_after":155250,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001741987-25-000008","document":"wk-form4_1762814517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000008/wk-form4_1762814517.xml","form_type":"4"}},{"id":1003403,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-10T22:41:59.000Z","date":"2025-11-06","kind":"sale","planned":true,"acquired":false,"shares":17250,"price":24.1823,"value":417144.675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.79 to $24.4493, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":98325,"source":{"system":"sec-edgar","filing":"0001741987-25-000008","document":"wk-form4_1762814517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000008/wk-form4_1762814517.xml","form_type":"4"}},{"id":1003402,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-10T22:41:59.000Z","date":"2025-11-06","kind":"exercise","planned":true,"acquired":true,"shares":17250,"price":3.64,"value":62790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."}],"balance_after":115575,"source":{"system":"sec-edgar","filing":"0001741987-25-000008","document":"wk-form4_1762814517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000008/wk-form4_1762814517.xml","form_type":"4"}},{"id":1006555,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-05T23:57:27.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":3864,"price":23.7172,"value":91643.2608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.52 to $23.865, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":98325,"source":{"system":"sec-edgar","filing":"0001741987-25-000005","document":"wk-form4_1762387044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000005/wk-form4_1762387044.xml","form_type":"4"}},{"id":1006554,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-05T23:57:27.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":15,"price":25.4,"value":381.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."}],"balance_after":102189,"source":{"system":"sec-edgar","filing":"0001741987-25-000005","document":"wk-form4_1762387044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000005/wk-form4_1762387044.xml","form_type":"4"}},{"id":1006553,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-05T23:57:27.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":2607,"price":24.7124,"value":64425.2268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.31 to $25.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":102204,"source":{"system":"sec-edgar","filing":"0001741987-25-000005","document":"wk-form4_1762387044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000174198725000005/wk-form4_1762387044.xml","form_type":"4"}},{"id":1059006,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-22T01:32:45.000Z","date":"2025-08-21","kind":"sale","planned":true,"acquired":false,"shares":2438,"price":15.5738,"value":37968.9244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on  December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"shares","element":"transactionShares","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on  December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.43 to $15.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":104811,"source":{"system":"sec-edgar","filing":"0001787306-25-000130","document":"wk-form4_1755826361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000130/wk-form4_1755826361.xml","form_type":"4"}},{"id":1059005,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-22T01:32:45.000Z","date":"2025-08-19","kind":"sale","planned":true,"acquired":false,"shares":1750,"price":16.1604,"value":28280.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.87 to $16.73, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":107249,"source":{"system":"sec-edgar","filing":"0001787306-25-000130","document":"wk-form4_1755826361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000130/wk-form4_1755826361.xml","form_type":"4"}},{"id":1068557,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-12T21:04:58.000Z","date":"2025-08-08","kind":"sale","planned":true,"acquired":false,"shares":3847,"price":14.0339,"value":53988.4133,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024 by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024 by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.992 to $14.12, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":108999,"source":{"system":"sec-edgar","filing":"0001787306-25-000126","document":"wk-form4_1755032693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000126/wk-form4_1755032693.xml","form_type":"4"}},{"id":1073863,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:28:58.000Z","date":"2025-08-04","kind":"sale","planned":true,"acquired":false,"shares":2622,"price":14.3266,"value":37564.3452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.965 to $14.675, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":112846,"source":{"system":"sec-edgar","filing":"0001787306-25-000118","document":"wk-form4_1754432935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000118/wk-form4_1754432935.xml","form_type":"4"}},{"id":1087870,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-14T20:02:23.000Z","date":"2025-07-14","kind":"exercise","planned":true,"acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":172500,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001787306-25-000106","document":"wk-form4_1752523337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000106/wk-form4_1752523337.xml","form_type":"4"}},{"id":1087869,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-14T20:02:23.000Z","date":"2025-07-10","kind":"exercise","planned":true,"acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":178250,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001787306-25-000106","document":"wk-form4_1752523337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000106/wk-form4_1752523337.xml","form_type":"4"}},{"id":1087868,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-14T20:02:23.000Z","date":"2025-07-14","kind":"sale","planned":true,"acquired":false,"shares":5750,"price":15.0702,"value":86653.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $15.00 to $15.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":115468,"source":{"system":"sec-edgar","filing":"0001787306-25-000106","document":"wk-form4_1752523337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000106/wk-form4_1752523337.xml","form_type":"4"}},{"id":1087867,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-14T20:02:23.000Z","date":"2025-07-14","kind":"exercise","planned":true,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."}],"balance_after":121218,"source":{"system":"sec-edgar","filing":"0001787306-25-000106","document":"wk-form4_1752523337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000106/wk-form4_1752523337.xml","form_type":"4"}},{"id":1087866,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-14T20:02:23.000Z","date":"2025-07-10","kind":"sale","planned":true,"acquired":false,"shares":23000,"price":15.0455,"value":346046.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $15.00 to $15.125, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in\nthis footnote."}],"balance_after":115468,"source":{"system":"sec-edgar","filing":"0001787306-25-000106","document":"wk-form4_1752523337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000106/wk-form4_1752523337.xml","form_type":"4"}},{"id":1087865,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-14T20:02:23.000Z","date":"2025-07-10","kind":"exercise","planned":true,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."}],"balance_after":138468,"source":{"system":"sec-edgar","filing":"0001787306-25-000106","document":"wk-form4_1752523337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000106/wk-form4_1752523337.xml","form_type":"4"}},{"id":1153252,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-09T23:45:47.000Z","date":"2025-05-08","kind":"sale","planned":true,"acquired":false,"shares":3871,"price":13.5942,"value":52623.1482,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on  December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.50 to $13.69, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":115468,"source":{"system":"sec-edgar","filing":"0002065881-25-000007","document":"wk-form4_1746834341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000206588125000007/wk-form4_1746834341.xml","form_type":"4"}},{"id":1158553,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-05T21:20:14.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":2597,"price":15.1877,"value":39442.4569,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted on February 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.75 to $15.5519, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":119339,"source":{"system":"sec-edgar","filing":"0001787306-25-000084","document":"wk-form4_1746480007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000084/wk-form4_1746480007.xml","form_type":"4"}},{"id":1203194,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-17T20:51:57.000Z","date":"2025-03-14","kind":"exercise","planned":true,"acquired":false,"shares":12242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":201250,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":12242},"source":{"system":"sec-edgar","filing":"0001787306-25-000045","document":"wk-form4_1742244710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000045/wk-form4_1742244710.xml","form_type":"4"}},{"id":1203193,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-17T20:51:57.000Z","date":"2025-03-13","kind":"exercise","planned":true,"acquired":false,"shares":5008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":213492,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":5008},"source":{"system":"sec-edgar","filing":"0001787306-25-000045","document":"wk-form4_1742244710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000045/wk-form4_1742244710.xml","form_type":"4"}},{"id":1203192,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-17T20:51:57.000Z","date":"2025-03-14","kind":"sale","planned":true,"acquired":false,"shares":12242,"price":15.039,"value":184107.438,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.1429, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":121936,"source":{"system":"sec-edgar","filing":"0001787306-25-000045","document":"wk-form4_1742244710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000045/wk-form4_1742244710.xml","form_type":"4"}},{"id":1203191,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-17T20:51:57.000Z","date":"2025-03-14","kind":"exercise","planned":true,"acquired":true,"shares":12242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":134178,"source":{"system":"sec-edgar","filing":"0001787306-25-000045","document":"wk-form4_1742244710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000045/wk-form4_1742244710.xml","form_type":"4"}},{"id":1203190,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-17T20:51:57.000Z","date":"2025-03-13","kind":"sale","planned":true,"acquired":false,"shares":5008,"price":15.1021,"value":75631.3168,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.34, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":121936,"source":{"system":"sec-edgar","filing":"0001787306-25-000045","document":"wk-form4_1742244710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000045/wk-form4_1742244710.xml","form_type":"4"}},{"id":1203189,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-17T20:51:57.000Z","date":"2025-03-13","kind":"exercise","planned":true,"acquired":true,"shares":5008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":126944,"source":{"system":"sec-edgar","filing":"0001787306-25-000045","document":"wk-form4_1742244710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000045/wk-form4_1742244710.xml","form_type":"4"}},{"id":1203188,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-17T20:51:57.000Z","date":"2025-03-13","kind":"sale","planned":true,"acquired":false,"shares":44153,"price":14.9655,"value":660771.7215,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of  February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.6545 to $15.35, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":121936,"source":{"system":"sec-edgar","filing":"0001787306-25-000045","document":"wk-form4_1742244710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000045/wk-form4_1742244710.xml","form_type":"4"}},{"id":1225975,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-05T00:44:03.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":43000,"derivative":{"exercise_price":13.69,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001787306-25-000043","document":"wk-form4_1741135437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000043/wk-form4_1741135437.xml","form_type":"4"}},{"id":1225974,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-05T00:44:03.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":99000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":99000,"derivative":{"exercise_price":13.69,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":99000},"source":{"system":"sec-edgar","filing":"0001787306-25-000043","document":"wk-form4_1741135437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000043/wk-form4_1741135437.xml","form_type":"4"}},{"id":1225973,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:44:03.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":954,"price":13.2841,"value":12673.0314,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, granted on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.28 to $13.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":166089,"source":{"system":"sec-edgar","filing":"0001787306-25-000043","document":"wk-form4_1741135437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000043/wk-form4_1741135437.xml","form_type":"4"}},{"id":1225972,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:44:03.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":2819,"price":13.0311,"value":36734.6709,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, granted on March 3, 2022 and March 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.6902 to $13.83, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":167043,"source":{"system":"sec-edgar","filing":"0001787306-25-000043","document":"wk-form4_1741135437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000043/wk-form4_1741135437.xml","form_type":"4"}},{"id":1225971,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:44:03.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the \"Vesting Commencement Date\"), of each year beginning March 1, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":169862,"source":{"system":"sec-edgar","filing":"0001787306-25-000043","document":"wk-form4_1741135437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000043/wk-form4_1741135437.xml","form_type":"4"}},{"id":1225970,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:44:03.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the \"Vesting Commencement Date\"), of each year beginning March 1, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":152862,"source":{"system":"sec-edgar","filing":"0001787306-25-000043","document":"wk-form4_1741135437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000043/wk-form4_1741135437.xml","form_type":"4"}},{"id":1283599,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-05T01:00:49.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":12116,"price":12.7,"value":153873.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligation in connection with the vesting of Restricted Stock Units (\"RSUs\"), granted on  January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the \"Vesting Commencement Date\"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.545 to $13.0096, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":114862,"source":{"system":"sec-edgar","filing":"0001787306-25-000014","document":"wk-form4_1738717243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730625000014/wk-form4_1738717243.xml","form_type":"4"}},{"id":1319630,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-12-31T23:13:51.000Z","date":"2024-12-31","kind":"sale","planned":true,"acquired":false,"shares":1691,"price":14,"value":23674.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units (\"RSUs\"), granted on August 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.8068 to $14.40, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":126978,"source":{"system":"sec-edgar","filing":"0001787306-24-000174","document":"wk-form4_1735686824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000174/wk-form4_1735686824.xml","form_type":"4"}},{"id":1350521,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-26T21:21:01.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":false,"shares":16023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting\nCommencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting\nPerson's continued service to the Issuer."}],"balance_after":218500,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":16023},"source":{"system":"sec-edgar","filing":"0001787306-24-000161","document":"wk-form4_1732656053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000161/wk-form4_1732656053.xml","form_type":"4"}},{"id":1350520,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-26T21:21:01.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":16023,"price":10.1426,"value":162514.8798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.205 to $10.14, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":128669,"source":{"system":"sec-edgar","filing":"0001787306-24-000161","document":"wk-form4_1732656053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000161/wk-form4_1732656053.xml","form_type":"4"}},{"id":1350519,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-26T21:21:01.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":true,"shares":16023,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144692,"source":{"system":"sec-edgar","filing":"0001787306-24-000161","document":"wk-form4_1732656053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000161/wk-form4_1732656053.xml","form_type":"4"}},{"id":1361284,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-19T00:04:23.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":234523,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001787306-24-000157","document":"wk-form4_1731974656.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000157/wk-form4_1731974656.xml","form_type":"4"}},{"id":1361283,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-19T00:04:23.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":false,"shares":18377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":234623,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":18377},"source":{"system":"sec-edgar","filing":"0001787306-24-000157","document":"wk-form4_1731974656.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000157/wk-form4_1731974656.xml","form_type":"4"}},{"id":1361282,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-19T00:04:23.000Z","date":"2024-11-15","kind":"sale","planned":false,"acquired":false,"shares":100,"price":10.03,"value":1003.0,"ownership":{"direct":true},"balance_after":128669,"source":{"system":"sec-edgar","filing":"0001787306-24-000157","document":"wk-form4_1731974656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000157/wk-form4_1731974656.xml","form_type":"4"}},{"id":1361281,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-19T00:04:23.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128769,"source":{"system":"sec-edgar","filing":"0001787306-24-000157","document":"wk-form4_1731974656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000157/wk-form4_1731974656.xml","form_type":"4"}},{"id":1361280,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-19T00:04:23.000Z","date":"2024-11-14","kind":"sale","planned":false,"acquired":false,"shares":18377,"price":10.2945,"value":189182.0265,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.4926 to $10.00, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":128669,"source":{"system":"sec-edgar","filing":"0001787306-24-000157","document":"wk-form4_1731974656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000157/wk-form4_1731974656.xml","form_type":"4"}},{"id":1361279,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-19T00:04:23.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":true,"shares":18377,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":147046,"source":{"system":"sec-edgar","filing":"0001787306-24-000157","document":"wk-form4_1731974656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000157/wk-form4_1731974656.xml","form_type":"4"}},{"id":1361278,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-19T00:04:23.000Z","date":"2024-11-14","kind":"sale","planned":false,"acquired":false,"shares":50749,"price":10.2945,"value":522435.5805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.4926 to $10.00, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":128669,"source":{"system":"sec-edgar","filing":"0001787306-24-000157","document":"wk-form4_1731974656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000157/wk-form4_1731974656.xml","form_type":"4"}},{"id":1374947,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:45:51.000Z","date":"2024-11-04","kind":"sale","planned":true,"acquired":false,"shares":15441,"price":8.6842,"value":134092.7322,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the Reporting Person's Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.32 to $8.86, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":179418,"source":{"system":"sec-edgar","filing":"0001787306-24-000142","document":"wk-form4_1730843144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000142/wk-form4_1730843144.xml","form_type":"4"}},{"id":1426246,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-21T20:39:18.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":1728,"price":8.286,"value":14318.208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the reporting person's Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.27 to $8.30, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":194859,"source":{"system":"sec-edgar","filing":"0001787306-24-000128","document":"wk-form4_1724272751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000128/wk-form4_1724272751.xml","form_type":"4"}},{"id":1440338,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-05T20:37:24.000Z","date":"2024-08-02","kind":"sale","planned":true,"acquired":false,"shares":13206,"price":9.0191,"value":119106.2346,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.74 to $9.26, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":196587,"source":{"system":"sec-edgar","filing":"0001787306-24-000117","document":"wk-form4_1722890238.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000117/wk-form4_1722890238.xml","form_type":"4"}},{"id":1496273,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:50:40.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 12, 2024, the Reporting Person was granted options,  in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":253000,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001787306-24-000085","document":"wk-form4_1717188632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000085/wk-form4_1717188632.xml","form_type":"4"}},{"id":1496272,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-31T20:50:40.000Z","date":"2024-05-30","kind":"sale","planned":false,"acquired":false,"shares":23000,"price":8.753,"value":201319.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $8.70 to $8.88, inclusive.  The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":209793,"source":{"system":"sec-edgar","filing":"0001787306-24-000085","document":"wk-form4_1717188632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000085/wk-form4_1717188632.xml","form_type":"4"}},{"id":1496271,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-31T20:50:40.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":232793,"source":{"system":"sec-edgar","filing":"0001787306-24-000085","document":"wk-form4_1717188632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000085/wk-form4_1717188632.xml","form_type":"4"}},{"id":1496270,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-31T20:50:40.000Z","date":"2024-05-29","kind":"sale","planned":false,"acquired":false,"shares":49952,"price":8.7161,"value":435386.6272,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $8.50 to $8.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":209793,"source":{"system":"sec-edgar","filing":"0001787306-24-000085","document":"wk-form4_1717188632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000085/wk-form4_1717188632.xml","form_type":"4"}},{"id":1527390,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-03T20:22:18.000Z","date":"2024-05-02","kind":"sale","planned":true,"acquired":false,"shares":9555,"price":8.7378,"value":83489.679,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligation in connection with the vesting of Restricted Stock  Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $8.47 to $9.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":259745,"source":{"system":"sec-edgar","filing":"0001787306-24-000068","document":"wk-form4_1714767714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000068/wk-form4_1714767714.xml","form_type":"4"}},{"id":1590705,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-06T22:12:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":4782,"price":11.1212,"value":53181.5784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $11.000 to $11.3200, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":269300,"source":{"system":"sec-edgar","filing":"0001787306-24-000040","document":"wk-form4_1709763131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000040/wk-form4_1709763131.xml","form_type":"4"}},{"id":1640493,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 2, 2023, and received in exchange for the option, these RSUs that vest in twelve equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The canceled option vest as to 1/48 of the shares subject to the option vest on each monthly anniversary measured from March 1, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":15.82,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":55800},"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1640492,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":47100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2022, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The canceled option vest as to 1/48 of the shares subject to the option vest on each monthly anniversary measured from March 1, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":17.67,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":47100},"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1640491,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2021, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The canceled option vest as to 1/48 of the shares subject to the option vest on each monthly anniversary measured from March 3, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":32.44,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":28800},"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1640490,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":320000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on August 3, 2020, and received in exchange for the option,  these Restricted Stock Units (\"RSUs\") that vest in four equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The canceled option vested as to 1/4 of the total shares on August 1, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vesting on August 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":25.89,"expiration_date":"2030-08-03","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1640489,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":27900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 2, 2023, and received in exchange for the option, these RSUs that vest in twelve equal quarterly installments commencing May 1, 2024."}],"balance_after":274082,"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1640488,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":23550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2022, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024."}],"balance_after":246182,"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1640487,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":9600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2021, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024"}],"balance_after":222632,"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1640486,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-15T23:36:10.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":128000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on August 3, 2020, and received in exchange for the option,  these Restricted Stock Units (\"RSUs\") that vest in four equal quarterly installments commencing May 1, 2024."}],"balance_after":213032,"source":{"system":"sec-edgar","filing":"0001787306-24-000020","document":"wk-form4_1708040155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000020/wk-form4_1708040155.xml","form_type":"4"}},{"id":1677471,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-17T21:35:52.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":276000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":276000,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":276000},"source":{"system":"sec-edgar","filing":"0001787306-24-000012","document":"wk-form4_1705527338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000012/wk-form4_1705527338.xml","form_type":"4"}},{"id":1677470,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-17T21:35:52.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute Restricted Stock Units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on February 1, (the \"Vesting Commencement Date\"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":85032,"source":{"system":"sec-edgar","filing":"0001787306-24-000012","document":"wk-form4_1705527338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000012/wk-form4_1705527338.xml","form_type":"4"}},{"id":1690637,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-03T22:30:56.000Z","date":"2024-01-02","kind":"sale","planned":false,"acquired":false,"shares":1325,"price":3.5408,"value":4691.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units (\"RSUs\"), granted on August 3, 2020. The sale is mandated by the Issuer's election  to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units (\"RSUs\"), granted on August 3, 2020. The sale is mandated by the Issuer's election  to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":57032,"source":{"system":"sec-edgar","filing":"0001787306-24-000002","document":"wk-form4_1704321036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730624000002/wk-form4_1704321036.xml","form_type":"4"}},{"id":1799367,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-22T16:24:31.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":1305,"price":7.04,"value":9187.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units (\"RSUs\"), granted on August 3, 2020. The sale is mandated by the Issuer's election  to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":58357,"source":{"system":"sec-edgar","filing":"0001787306-23-000083","document":"wk-form4_1692721462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730623000083/wk-form4_1692721462.xml","form_type":"4"}},{"id":1799366,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-22T16:24:31.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":300,"price":7.05,"value":2115.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units (\"RSUs\"), granted on August 3, 2020. The sale is mandated by the Issuer's election  to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":59662,"source":{"system":"sec-edgar","filing":"0001787306-23-000083","document":"wk-form4_1692721462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730623000083/wk-form4_1692721462.xml","form_type":"4"}},{"id":1962459,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-08T21:28:28.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":851,"price":15.2634,"value":12989.1534,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $15.120 to $15.440, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":59962,"source":{"system":"sec-edgar","filing":"0001567619-23-004670","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761923004670/doc1.xml","form_type":"4"}},{"id":1968102,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T23:51:46.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":55800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 2, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":55800,"derivative":{"exercise_price":15.82,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":55800},"source":{"system":"sec-edgar","filing":"0001567619-23-004541","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761923004541/doc1.xml","form_type":"4"}},{"id":1968101,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T23:51:46.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 2 of each year, beginning March 2, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":60813,"source":{"system":"sec-edgar","filing":"0001567619-23-004541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761923004541/doc1.xml","form_type":"4"}},{"id":1968100,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T23:51:46.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":23,"price":16.52,"value":379.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":39813,"source":{"system":"sec-edgar","filing":"0001567619-23-004541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761923004541/doc1.xml","form_type":"4"}},{"id":1968099,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T23:51:46.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":1728,"price":15.8178,"value":27333.1584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $15.470 to $16.460, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":39836,"source":{"system":"sec-edgar","filing":"0001567619-23-004541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761923004541/doc1.xml","form_type":"4"}},{"id":2065407,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-04T22:15:26.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1475,"price":15.0075,"value":22136.0625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units (\"RSUs\"), granted on August 3, 2020. The sale is mandated by the Issuer's election  to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units (\"RSUs\"), granted on August 3, 2020. The sale is mandated by the Issuer's election  to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":41564,"source":{"system":"sec-edgar","filing":"0001787306-23-000002","document":"wf-form4_167287050853068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000178730623000002/wf-form4_167287050853068.xml","form_type":"4"}},{"id":2346963,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T01:53:00.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":47100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 3, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":47100,"derivative":{"exercise_price":17.67,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":47100},"source":{"system":"sec-edgar","filing":"0001567619-22-006497","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761922006497/doc1.xml","form_type":"4"}},{"id":2346962,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-08T01:53:00.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":30,"price":16.4449,"value":493.347,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $16.44 to $16.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 41,675 RSUs."}],"balance_after":43039,"source":{"system":"sec-edgar","filing":"0001567619-22-006497","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761922006497/doc1.xml","form_type":"4"}},{"id":2346961,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-08T01:53:00.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":981,"price":16.8591,"value":16538.7771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $16.63 to $17.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":43069,"source":{"system":"sec-edgar","filing":"0001567619-22-006497","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761922006497/doc1.xml","form_type":"4"}},{"id":2346960,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-08T01:53:00.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":17800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 3 of each year, beginning March 3, 2023, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":44050,"source":{"system":"sec-edgar","filing":"0001567619-22-006497","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761922006497/doc1.xml","form_type":"4"}},{"id":2447162,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-05T02:05:30.000Z","date":"2021-12-30","kind":"grant","acquired":true,"shares":16750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2020, the Reporting Person was granted performance-based restricted stock units (\"RSUs\") subject to a milestone condition. The Compensation Committee of the Issuer certified the achievement of the milestone and commencement of vesting on December 30, 2021 (the \"Milestone Vesting Commencement Date\"). 25% of the performance-based RSUs shall vest annually from the Milestone Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26,250 RSUs."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001567619-22-000389","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761922000389/doc1.xml","form_type":"4"}},{"id":2805128,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":20722,"kind":"person","name":"Burnett Patrick","position":1,"cik":"0001741987","reported_name":"Burnett Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T20:54:12.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":28800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 3, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":28800,"derivative":{"exercise_price":32.44,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":28800},"source":{"system":"sec-edgar","filing":"0001567619-21-005733","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741987/000156761921005733/doc1.xml","form_type":"4"}}],"next_cursor":"2021-03-05T20:54:12.000000Z,2805128"}